cancer vaccines
Personalized Neoantigen Vaccine Shows Feasibility but Limited Efficacy in MSS Colorectal Cancer
Premium
Researchers at AACR's annual meeting said they hope the vaccine will show stronger efficacy in patients with minimal residual disease.
NHS England Partners With Scancell to Expand Cancer Vaccine Trial in Melanoma
In the trial, researchers are evaluating Scancell's DNA cancer vaccines SCIB1 and iSCIB1+ alongside immunotherapy.
The firms hope to show that Verdi's off-the-shelf peptide cancer vaccine can shrink tumors and improve quality of life in patients with bone metastases.
Nouscom to Advance Cancer Vaccine for Lynch Syndrome Into Registrational Study
The firm says it has a path forward for a Phase II/III registration-enabling study of NOUS-209 after positive meetings with the FDA.
Anixa Biosciences Nabs Option to Develop Cancer Vaccines With Verdi Solutions
If Anixa exercises its rights, Verdi and Anixa will collaborate on trials in the US, while Verdi will continue developing personalized vaccines in Europe.
Feb 1, 2024
Evaxion Biotech Prices $15M Public Offering
Nov 17, 2023
Oct 5, 2023